Arunjyoti Bio Ventures Limited

BSE: ABVL530881ISIN INE485K01022

Financial Services
Other Financial Services

BSE listing

Share price

₹4.33-0.17 (-3.78%)

as of 18 Sep 2026

52W high: ₹12.71
52W low: ₹3.78
Off 52W high: -65.93%
1M return: -13.92%
3M return: -25.09%
6M return: -38.23%
1Y return: -48.33%
20D avg volume: 1,75,095
50 DMA: ₹5.08
200 DMA: ₹6.68

Key ratios Standalone

Market cap: ₹80.70 Cr
Current price: ₹4.33
52W high / low: ₹12.71 / ₹3.78
Face value: ₹1.00
P/E: —
P/B: 2.20
EPS (TTM): —
Book value / share: ₹1.97
ROE: -6.49%
ROCE: -7.60%
Operating margin: 25.65%
Net margin: 7.46%
Debt / equity: 0.76
Net debt: ₹21.62 Cr
Interest cover: -1.51
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 28.2 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	8.20	7.24	6.47	—	8.71	5.28	—
	0.02	0.08	0.01	—	0.01	0.01	—
	7.40	10.88	6.41	—	6.56	6.34	—
	0.00	0.00	0.00	—	0.00	0.00	—
	0.00	0.00	0.00	—	0.96	0.47	—
	2.99	3.43	2.55	—	2.63	2.58	—
	0.44	0.40	0.52	—	0.62	0.59	—
	0.84	0.87	0.84	—	—	0.80	—
	3.13	6.19	2.50	—	1.84	2.23	—
	0.82	-3.57	0.07	—	—	-1.04	—
	0.00	-2.74	0.00	—	—	0.00	—
	0.82	-6.30	0.07	—	2.17	-1.04	—
	0.21	-0.90	0.02	—	-0.19	0.95	—
	0.61	-5.40	0.05	—	2.36	-1.99	—
	0.03	-0.29	0.00	—	0.13	-0.11	—
Key metrics
	2.10	-5.03	1.43	—	2.79	0.35	—
	25.60%	-69.50%	22.10%	—	32.00%	6.60%	—
	7.40%	-74.60%	0.80%	—	27.10%	-37.70%	—
	—	-14.50%	—	—	—	-0.80%	—
	-5.90%	37.10%	—	—	—	—	—
	-74.20%	-171.40%	—	—	—	—	—

Metric	FY26	FY25	FY24
Income statement
	27.75	27.88	—
	0.12	0.28	—
	30.28	28.51	—
	0.00	0.00	—
	0.00	4.92	—
	11.23	9.01	—
	2.05	2.59	—
	3.36	3.05	—
	13.64	8.64	—
	-2.40	-0.34	—
	-2.74	0.00	—
	-5.14	-0.34	—
	-0.60	1.48	—
	-4.54	-1.82	—
	-0.24	-0.10	—
Key metrics
	0.27	5.30	—
	1.00%	19.00%	—
	-16.40%	-6.50%	—
	-7.60%	4.10%	—
	-0.50%	—	—
	-149.50%	—	—
	7.45	-4.42	—
	-2.28	-0.80	—
	0.76	0.79	—
	21.62	25.03	—
	28.2	86.1	—
Balance sheet
	54.16	59.62	—
	5.72	14.80	—
	0.13	0.59	—
	3.84	3.96	—
	0.11	2.62	—
	0.36	7.14	—
	42.40	43.33	—
	1.80	0.00	—
	13.40	5.29	—
	21.75	25.62	—
	10.25	4.69	—
	11.50	20.93	—
	28.72	32.38	—
Cash flow
	10.36	1.45	—
	-4.84	-5.59	—
	-5.99	4.65	—
	2.91	5.87	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 47.63%

Holder	Type	Holding	Previous	Change
DATHVIK PABBATHI	Promoter	23.07%	—	—
PABBATHI BADARI NARAYANA MURTHY	Promoter	19.25%	—	—
PONNURU SIVA RATNA MAHA LAKSHMI PRASANNA	Promoter	5.31%	—	—
CHENNUPATI SARATH KUMAR	Public	4.23%	—	—
VANAJA VEERAMREDDY	Public	3.73%	—	—
SREEDAR REDDY G	Public	3.12%	—	—
SHASHANK SAI PABBATHI	Public	2.54%	—	—
SANIVARAPU JHANSI	Public	2.37%	—	—
SIRISHA PABBATHI	Public	2.06%	—	—
SANDEEP KAPADIA	Public	1.93%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Change of Name of the Company from "Arunjyoti Bio Ventures Limited" to "Pasura Industries Limited"3 Sep 2026 · Company Update / Change of Name
Scrutinizer Report for 40th Annual General Meeting12 Aug 2026 · AGM/EGM / AGM
Outcome & Proceedings of 40th Annual General Meeting12 Aug 2026 · AGM/EGM / AGM
Annual Report for FY 2025-26 of the Company.20 Jul 2026 · Others / Reg. 34 (1) Annual Report
Notice of AGM for the FY 2025-26 scheduled to be held on 12.08.202620 Jul 2026 · AGM/EGM / AGM
Changes in Management9 Jul 2026 · Company Update / Change in Management
Un-Audited Financial Results along with Limited Review Report for the Quarter Ended 30.06.2026.9 Jul 2026 · Result / Financial Results
Certificate under Reg 74(5) of SEBI(DP) Regulations, 2018.8 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2026 ,inter alia, to consider and approve 1. Un-audited Financial ....4 Jul 2026 · Board Meeting / Board Meeting
Closure of Trading Window for Un-audited Financial Results for the Quarter ending 30.06.2026.24 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Annual Secretarial Compliance Report for the FY ended 31.03.202626 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Newspaper Publication for the Audited Financial Results for the Quarter and year ended 31.03.202614 May 2026 · Company Update / Newspaper Publication
Audited Financial Statements for the Quarter and Year ended 31.03.202613 May 2026 · Result / Financial Results
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve Audited Financial Results ....12 May 2026 · Company Update / Board Meeting Rescheduled
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve Audited Financial Results ....5 May 2026 · Company Update / Board Meeting Rescheduled
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 ,inter alia, to consider and approve Audited Financials results ....1 May 2026 · Board Meeting / Board Meeting
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....30 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....30 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chennupati Sarath Kumar17 Apr 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Clarification in trading of the shares of the Company.13 Apr 2026 · Company Update / General
Compliance Certificate under SEBI (DP) Regulations, 201813 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chennupati Sarath Kumar11 Apr 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Closure of Trading Window30 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of Installation and commisioning of New Jelly Pouch Production Line10 Mar 2026 · Company Update / General
Unauited Financial Results along with Limited Review Report for the quarter ended 31.12.20253 Feb 2026 · Result / Financial Results
Approval of Un-audited financial results along with the Limited Review Report for the quarter ended 31.12.20253 Feb 2026 · Board Meeting / Outcome of Board Meeting
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve Un-audited financial ....30 Jan 2026 · Board Meeting / Board Meeting
Compliance Certificate13 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of trading window26 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
Outcome3 Nov 2025 · Board Meeting / Outcome of Board Meeting
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 ,inter alia, to consider and approve Un-audited Financial ....27 Oct 2025 · Board Meeting / Board Meeting
Certificate u/r. 75(5)13 Oct 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of trading window for unaudited financial results for the quarter and half year ending 30.09.2025.26 Sep 2025 · Insider Trading / SAST / Closure of Trading Window
Outcome of Annual General Meeting10 Sep 2025 · AGM/EGM / AGM
Annual report19 Aug 2025 · Others / Reg. 34 (1) Annual Report
Intimation on registration of land6 Aug 2025 · Company Update / General
Outcome4 Aug 2025 · Board Meeting / Outcome of Board Meeting
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 ,inter alia, to consider and approve Un-audited financial ....28 Jul 2025 · Board Meeting / Board Meeting
Certificate under reg. 74(5)11 Jul 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
closure of trading window30 Jun 2025 · Insider Trading / SAST / Closure of Trading Window

Corporate actions

Purpose	Ex date	Record date	Payment date
Stock Split From Rs.10/- to Rs.1/-	17 Jan 2025	17 Jan 2025	—